NCT04064515View on ClinicalTrials.gov

CTCs in Cervix Cancer

CompletedOBSERVATIONAL
Enrollment

4

Participants

Timeline

Start Date

March 2, 2020

Primary Completion Date

April 23, 2020

Study Completion Date

April 23, 2020

Conditions
Cervical CancerHPV
Interventions
DIAGNOSTIC_TEST

Blood Assayed for CTCs

All study participants will have 15 mL of blood drawn for the purpose of the study.

Trial Locations (1)

10016

NYU Langone Health, New York

All Listed Sponsors
lead

NYU Langone Health

OTHER

NCT04064515 - CTCs in Cervix Cancer | Biotech Hunter | Biotech Hunter